Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 30, 2015 9:27 AM ET

Biotechnology

Company Overview of Virobay Inc.

Key Executives for Virobay Inc.

NameBoard RelationshipsTitleAge
Robert F. G. Booth Ph.D.22 RelationshipsCo-Founder, Chairman, Chief Executive Officer, President and Secretary60
Heather Preston M.D.50 RelationshipsCo-Founder, Director, Chairperson of Nominating & Corporate Governance Committee and Member of Audit Committee48
Kyle C. Elrod B.A.No RelationshipsSenior Vice President of Project Management and Operations47
Elizabeth G. Shigezumi No RelationshipsHead of Clinical Operations and Clinical Trial Manager of Clinical Operations55

Virobay Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert F. G. Booth Ph.D. 22 RelationshipsVirobay Inc.60
Heather Preston M.D. 50 RelationshipsVirobay Inc.48
Thomas John Dietz Ph.D. 48 RelationshipsTranscept Pharmaceuticals, Inc.50
Daniel S. Janney MBA 87 RelationshipsAlta Partners LP48
Jeffrey W. Bird M.D., Ph.D. 98 RelationshipsSutter Hill Ventures53
View All Board Members

Virobay Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Thomas John Dietz48 Relationships3 Executives
Compensation Committee Ph.D.Thomas John Dietz48 Relationships3 Executives
Nominating Committee M.D.Heather Preston50 Relationships3 Executives
Corporate Governance Committee M.D.Heather Preston50 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$355.4K
355.4K
361.3K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$355.4K
355.4K
30.0M
Compensation as of Fiscal Year 2013
Virobay Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Pee Cee Cosma Sope Ltd Announces Executive Changes
June 23, 2015 9:49 AM ET
Kimberly-Clark Elects Michael D. White to its Board of Directors
June 22, 2015 1:00 PM ET
Hipolin Announces Resignation of Nilesh Rajnikant Desai as Independent Director
June 10, 2015 10:30 AM ET
Frank A. Tataseo, Executive Vice President - New Business Development to Retire from the Clorox Company, Effective October 1, 2015
June 03, 2015 9:00 PM ET
Lokesh Sah Joins as Vice President on Reckitt Benckiser
June 03, 2015 10:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Virobay Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.